8 completed. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 8 |
Follow Tecfidera: new trials by email Literature Review of Tecfidera trials Research Report on Tecfidera
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China Dimethyl fumarate - Multiple Sclerosis | Phase 4 | Completed | Biogen | 60 | 2023-06-09 | 2025-05-16 |
| Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) Tecfidera, Placebo - Multiple Sclerosis (MS) | Phase 4 | Completed | University of Texas Southwestern Medical Center | 87 | 2016-03-19 | 2022-05-11 |
| Tecfidera and the Gut Microbiota dimethyl fumarate, injectable MS DMT - Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Completed | Biogen | 36 | 2015-11-06 | 2021-09-05 |
| Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera dimethyl fumarate, montelukast, Placebo - Multiple Sclerosis | Phase 4 | Completed | Biogen | 102 | 2015-03-12 | 2020-03-31 |
| Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany dimethyl fumarate - Relapsing-Remitting Multiple Sclerosis | Phase 4 | Completed | Biogen | 214 | 2014-06-01 | 2017-04-18 |
| Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis dimethyl fumarate, acetylsalicylic acid, ASA-Placebo - Relapsing-Remitting Multiple Sclerosis | Phase 4 | Completed | Biogen | 241 | 2014-05-01 | 2016-12-28 |
| A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes dimethyl fumarate - Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis | Phase 4 | Completed | Biogen | 1114 | 2013-10-31 | 2020-03-19 |
| Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States BG00012 (DMF) - Relapsing Forms of Multiple Sclerosis | Phase 4 | Completed | Biogen | 237 | 2013-05-01 | 2017-03-21 |
Multiple Sclerosis (5) · Multiple Sclerosis, Relapsing-Remitting (4) · Flushing (1)
Biogen (7) · University of Texas Southwestern Medical Center (1)
United States (3) · Austria (1) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Ireland (1) · Italy (1) · Norway (1) · Portugal (1) · Slovakia (1) · Slovenia (1)
PMID 19073949, PMID 31832225, PMID 36401339
2015 (1)